E. Mossdorf

Preparing for future waves and pandemics: a global hospital survey on infection control measures and infection rates in COVID-19

D. Kuritzkes, S. Erb, S. Quek, 2021, Antimicrobial resistance and infection control.

Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition

M. Tanner, M. Battegay, S. Abdulla, 2011, BMC infectious diseases.

Antihistamines are superior to topical steroids in managing Human Immunodeficiency Virus (HIV)‐associated papular pruritic eruption

M. Tanner, P. Schmid‐Grendelmeier, A. Navarini, 2010, International journal of dermatology.

Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts: clues towards a rational vaccination strategy

M. Battegay, C. Hess, I. Steffen, 2010, AIDS.

Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients.

M. Cavassini, P. Schmid, M. Niedrig, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of a national HIV voluntary counselling and testing (VCT) campaign on VCT in a rural hospital in Tanzania

M. Tanner, M. Battegay, S. Abdulla, 2010, Tropical medicine & international health : TM & IH.

Treatment of an atazanivir associated grade 4 hyperbilirubinaemia with efavirenz

M. Battegay, S. Krähenbühl, L. Elzi, 2007, Gut.

Bioavailability of extended-release nevirapine 400 and 300 mg in HIV-1: a multicenter, open-label study.

Wei Zhang, Manuel Battegay, Sreeraj Macha, 2011, Clinical therapeutics.

Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection

R. Weber, P. Soccal, L. Kaiser, 2008, AIDS.

Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts: clues towards a rational vaccination strategy

M. Battegay, C. Hess, I. Steffen, 2010, AIDS (London).